Predictive ability of C-reactive protein for early mortality after ischemic stroke: Comparison with NIHSS score

Acta Neurologica Belgica

Volumn 114, Issue 1, 2014, Pages 41-45

  Ghabaee, Mojdeh ^a,b   Zandieh, Ali ^a   Mohebbi, Shahrzad ^b   Fakhri, Mohammad ^a   Sadeghian, Homa ^a   Divani, Fatemeh ^a   Amirifard, Hamed ^b   Mousavi Mirkala, Mohammadreza ^a   Ghaffarpour, Majid ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

High sensitivity C reactive protein; Ischemic stroke; Mortality; National institutes of health stroke scale

Indexed keywords

C REACTIVE PROTEIN;

AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX; SMOKING; SURVIVAL PREDICTION; YOUDEN INDEX;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE; UNITED STATES;

EID: 84896879564     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-013-0238-y     Document Type: Article

References (33)

1. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16): 1685-1695. doi: 10. 1056/NEJMra043430.
2. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC (2007) C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 195(2): e195-e202. doi: 10. 1016/j. atherosclerosis. 2007. 07. 006.
3. Hamer M, Chida Y, Stamatakis E (2010) Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality. Clin Chem 56(1): 132-135. doi: 10. 1373/clinchem. 2009. 130740.
4. Bova IY, Bornstein NM, Korczyn AD (1996) Acute infection as a risk factor for ischemic stroke. Stroke 27(12): 2204-2206.
5. Grau AJ (1997) Infection, inflammation, and cerebrovascular ischemia. Neurology 49(5 Suppl 4): S47-S51.
6. Wang PY, Kao CH, Mui MY, Wang SJ (1993) Leukocyte infiltration in acute hemispheric ischemic stroke. Stroke 24(2): 236-240.
7. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122(2): 135-139.
8. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9): 391-397. p[ii]: S0166-2236(99)01401-0.
9. Nilupul Perera M, Ma HK, Arakawa S, Howells DW, Markus R, Rowe CC, Donnan GA (2006) Inflammation following stroke. J Clin Neurosci 13(1): 1-8. doi: 10. 1016/j. jocn. 2005. 07. 005.
10. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ, Dippel DW (2009) C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol 256(12): 2003-2008. doi: 10. 1007/s00415-009-5228-x.
11. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, Jefferson AL, Cohen RA (2006) C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 13(5): 540-546. doi: 10. 1016/j. jocn. 2005. 08. 010.
12. Di Napoli M, Papa F, Bocola V (2001) C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32(4): 917-924.
13. Lau AY, Wong EH, Leung TW, Mok VC, Wong KS (2012) Intravenous alteplase for Chinese patients with stroke and borderline eligibility. J Clin Neurosci 19(10): 1383-1386. doi: 10. 1016/j. jocn. 2012. 01. 027.
14. Zandieh A, Kahaki ZZ, Sadeghian H, Fakhri M, Pourashraf M, Parviz S, Ghaffarpour M, Ghabaee M (2013) A simple risk score for early ischemic stroke mortality derived from National Institutes of Health Stroke Scale: a discriminant analysis. Clin Neurol Neurosurg 115(7): 1036-1039. doi: 10. 1016/j. clineuro. 2012. 10. 034.
15. Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR (1999) Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 30(8): 1534-1537.
16. Meyer BC, Lyden PD (2009) The modified National Institutes of Health Stroke Scale: its time has come. Int J Stroke 4(4): 267-273. doi: 10. 1111/j. 1747-4949. 2009. 00294. x.
17. Mittal M, Rymer M, Lai SM (2012) Should all patients with mild ischemic stroke be excluded from therapeutic stroke trials? J Clin Neurosci 19(11): 1486-1489. doi: 10. 1016/j. jocn. 2012. 03. 008.
18. Gu Y, Ni W, Jiang H, Ning G, Xu B, Tian Y, Xu F, Liao Y, Song D, Mao Y (2012) Efficacy of extracranial-intracranial revascularization for non-moyamoya steno-occlusive cerebrovascular disease in a series of 66 patients. J Clin Neurosci 19(10): 1408-1415. doi: 10. 1016/j. jocn. 2011. 11. 037.
19. Adams HP Jr, Bendixen BH, Leira E, Chang KC, Davis PH, Woolson RF, Clarke WR, Hansen MD (1999) Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53(1): 122-125.
20. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS (2009) Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 40(12): 3777-3783. doi: 10. 1161/STROKEAHA. 109. 561431.
21. Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L (2009) Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurol 9: 18. doi: 10. 1186/1471-2377-9-18.
22. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T (1980) Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58(1): 113-130.
23. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1): 35-41.
24. Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258(4): 677-685. doi: 10. 1007/s00415-011-6006-0.
25. Cho KH, Kang DW, Kwon SU, Kim JS (2009) Lesion volume increase is related to neurologic progression in patients with subcortical infarction. J Neurol Sci 284(1-2): 163-167. doi: 10. 1016/j. jns. 2009. 05. 013.
26. Tei H, Uchiyama S, Usui T, Ohara K (2011) Diffusion-weighted ASPECTS as an independent marker for predicting functional outcome. J Neurol 258(4): 559-565. doi: 10. 1007/s00415-010-5787-x.
27. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC (1999) Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS investigators. Stroke 30(2): 293-298.
28. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR (1999) C-reactive protein and outcome after ischemic stroke. Stroke 30(5): 981-985.
29. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK (2008) Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 39(8): 2318-2324. doi: 10. 1161/STROKEAHA. 107. 510362.
30. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G (2011) Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 77(14): 1338-1345. doi: 10. 1212/WNL. 0b013e31823152b1.
31. Esteghamati A, Zandieh A, Zandieh B, Khalilzadeh O, Esteghamati S, Meysamie A, Nakhjavani M (2012) Comparing abilities of different lipid measures in diagnosis of insulin resistance: a survey of risk factors of non-communicable diseases (SuRFNCD-2007) study. Metab Syndr Relat Disord 10(1): 63-69. doi: 10. 1089/met. 2011. 0002.
32. Esteghamati A, Zandieh A, Zandieh B, Khalilzadeh O, Meysamie A, Nakhjavani M, Gouya MM (2011) Leptin cut-off values for determination of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Endocrine 40(1): 117-123. doi: 10. 1007/s12020-011-9447-4.
33. Zandieh A, Esteghamati A, Morteza A, Noshad S, Khalilzadeh O, Gouya MM, Nakhjavani M (2012) Appropriate BMI cut-off values for identification of metabolic risk factors: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Ann Hum Biol 39(6): 484-489. doi: 10. 3109/03014460. 2012. 716860.